我们所展示的质粒图谱主要是从文献和开放数据库中收集而来,主要是为了方便研究工作,其中一小部分质粒进行了质量控制,可供科学家使用。

所有的产品都严格仅供科学研究使用,不能应用于临床试验,包括人体摄入、注射或外用的药理学用途。

确保质粒的关键元件正确,但是我们并不能保证实验结果。页面展示的图谱序列为理论序列,可能与测序结果不一致,请自行比对后确定是否满足要求。(如果测过序,本页面一般会提供下载)

开放数据库中的大多数载体序列都没有被完全测序。如果实际序列与参考序列的相似度超过99%,则将其视为正确。

由于科学研究是在探索未知,具有很大的不确定性,在任何情况下,我们都不承担超出质粒本身的额外经济损失或责任。

载体名称:
pQTEV
载体抗性:
Ampicillin
载体长度:
4803 bp
载体类型:
Cloning vector
复制子:
ori
载体来源:
Scheich C, Niesen FH, Seckler R, Bussow K.

pQTEV 载体图谱

pQTEV4803 bp6001200180024003000360042004800T5 promoterlac operatorRBStranslation start site for inserts cloned into the multiple cloning site7xHismultiple cloning site; includes BamHI, SalI, BglII, KpnI, NotI and HindIII restriction siteslambda t0 terminatorCmRrrnB T1 terminatorCAP binding sitelacIlacIq promoterbomoriAmpRAmpR promoter

质粒操作方法

1. 发货形式:质粒干粉(常温运输,存于-20度,请务必先转化提质粒后使用)

2. 收到质粒干粉后请先5000rpm离心1min,再加入20μl ddH2O溶解质粒;(质粒复测的浓度有时候与标称值差距较大,这可能是因为冻干质粒在管中的位置、复溶效率、测量偏差以及管壁的吸附导致,因此建议先转化提质粒后再使用)

3. 取1支100μl 感受态于冰上解冻10min,加入2μl质粒,再冰浴30min后,42℃热激60s,不要搅动,再冰浴2min;

4. 加入900μl无抗的LB液体培养基,180rpm震荡37℃培养45min (30℃培养1-1.5小时);

5. 6000rpm离心5min,仅留100μl上清液重悬细菌沉淀,并涂布至目标质粒抗性的LB平板上;

6. 将平板倒置37℃培养14h,如果要求是30℃则培养20h; (菌落过多则将质粒稀释后再转化;没有菌落则加入10μl质粒转化;建议不要直接转表达感受态, 要先转克隆感受态,重提质粒后再导入表达感受态);

7. 挑取单菌落至LB液体培养基中,加入对应抗生素,220rpm震荡培养14h,根据实验需要和质粒提取试剂盒说明书提取质粒。

pQTEV 载体序列

LOCUS       40924_36258        4803 bp DNA     circular SYN 18-DEC-2018
DEFINITION  Cloning vector pQTEV, complete sequence.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 4803)
  AUTHORS   Scheich C, Niesen FH, Seckler R, Bussow K.
  TITLE     An automated in vitro protein folding screen applied to a human 
            dynactin subunit
  JOURNAL   Protein Sci. 13 (2), 370-380 (2004)
  PUBMED    14739323
REFERENCE   2  (bases 1 to 4803)
  AUTHORS   Bussow K.
  TITLE     Construction of expression vector pQTEV
  JOURNAL   Unpublished
REFERENCE   3  (bases 1 to 4803)
  AUTHORS   Bussow K.
  TITLE     Direct Submission
  JOURNAL   Submitted (25-FEB-2003) Prof. H. Lehrach, Max Planck Institute for 
            Molecular Genetics, Ihnestr. 73, Berlin 14195, Germany
REFERENCE   4  (bases 1 to 4803)
  TITLE     Direct Submission
REFERENCE   5  (bases 1 to 4803)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Protein 
            Sci."; date: "2004"; volume: "13"; issue: "2"; pages: "370-380"
COMMENT     SGRef: number: 2; type: "Journal Article"; journalName: 
            "Unpublished"
COMMENT     SGRef: number: 3; type: "Journal Article"; journalName: "Submitted 
            (25-FEB-2003) Prof. H. Lehrach, Max Planck Institute for Molecular 
            Genetics, Ihnestr. 73, Berlin 14195, Germany"
COMMENT     SGRef: number: 4; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..4803
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     promoter        10..54
                     /label=T5 promoter
                     /note="bacteriophage T5 promoter for E. coli RNA
                     polymerase, with embedded lac operator"
     protein_bind    62..78
                     /label=lac operator
                     /bound_moiety="lac repressor encoded by lacI"
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be 
                     relieved by adding lactose or 
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     RBS             97..108
                     /note="strong bacterial ribosome binding site (Elowitz and 
                     Leibler, 2000)"
     regulatory      101..107
                     /regulatory_class="ribosome_binding_site"
     misc_feature    115
                     /note="translation start site for inserts cloned into the 
                     multiple cloning site"
     CDS             121..141
                     /label=7xHis
                     /note="6xHis affinity tag"
     CDS             166..186
                     /label=TEV site
                     /note="tobacco etch virus (TEV) protease recognition and 
                     cleavage site"
     misc_feature    183..244
                     /note="multiple cloning site; includes BamHI, SalI, BglII,
                     KpnI, NotI and HindIII restriction sites"
     terminator      260..354
                     /label=lambda t0 terminator
                     /note="transcription terminator from phage lambda"
     CDS             398..1054
                     /label=CmR
                     /note="chloramphenicol acetyltransferase"
     terminator      1122..1208
                     /label=rrnB T1 terminator
                     /note="transcription terminator T1 from the E. coli rrnB
                     gene"
     protein_bind    complement(1267..1288)
                     /label=CAP binding site
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     CDS             complement(1304..2383)
                     /label=lacI
                     /note="lac repressor"
     promoter        complement(2384..2461)
                     /label=lacIq promoter
                     /note="In the lacIq allele, a single base change in the
                     promoter boosts expression of the lacI gene about 10-fold."
     misc_feature    2653..2793
                     /label=bom
                     /note="basis of mobility region from pBR322"
     rep_origin      complement(2979..3567)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     CDS             complement(3741..4598)
                     /label=AmpR
                     /note="beta-lactamase"
     promoter        complement(4599..4703)
                     /label=AmpR promoter